Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus

International Journal of Colorectal Disease

Volumn 18, Issue 2, 2003, Pages 167-171

  Taussky, Daniel ^a,c   Rousson, Valentin ^b   Pescia, Raoul ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Esophageal cancer; Hypoxia; Radio chemotherapy; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN; ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG USE; ESOPHAGUS CARCINOMA; HUMAN; HYPOXIA; IN VIVO STUDY; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TISSUE OXYGENATION; TREATMENT FAILURE; CELL HYPOXIA; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0038052157     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-002-0435-2     Document Type: Article

References (26)

1. Herskovic A, Martz K, Al-Sarraf M, et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598
2. Coia LR, Minsky BD, John MJ, et al (1999) The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus. Cancer 85:2499-2505
3. Blanke CD, Choy H, Leach SD (1997) Combined modality therapy for esophageal carcinoma. Semin Radiat Oncol 7:15-23
4. Coia LR (1994) Chemoradiation as primary management of esophageal cancer. Semin Oncol 21:483-492
5. Leichmann LP (2000) Role and context of definitive nonoperative therapy for esophageal cancer. American Society of Clinical Oncology Educational Book, New York, pp 516-522
6. Smalley SR, Gunderson LL, Reddy EK, Williamson S (1994) Radiotherapy alone in esophageal carcinoma: current management and future directions of adjuvant, curative, and palliative approaches. Semin Oncol 21:467-473
7. Blanke CD, Choy H, Leach SD (1997) Combined modality therapy for esophageal cancer. Semin Radiother Oncol 7:15-23
8. Brizel DM, Scully SP, Harrelson JM, et al (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941-943
9. Sundfor K, LynH, Trope CG, Rofstad EK (2000) Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumour oxygenation and vascularization. Radiother Oncol 54:101-107
10. Nordsmark M, Overgaard M, Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41:31-39
11. Fyles AW, Milosevic M, Wong R, et al (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149-156
12. Hoeckel M, Schlenger K, Mitze M, Schaeffer U, Vaupel P (1996) Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6:3-9
13. Overgaard J, Horsman MR (1996) Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 6:10-21
14. Lieberman MD, Shriver CD, Bleckner S, Burt M (1995) Carcinoma of the esophagus. Prognostic significance of histology. J Thorac Cardiovasc Surg 109:130-138
15. Petrequin P, Huguier M, Line F, Houry S (1997) Surgically treated esophageal cancers: predictive model of survival. Gastroenterol Clin Biol 21:17-16
16. Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J (1995) Multivariate analysis of the prognostic ad predictive factors of response to concomitant radiochemotherapy in epidermoid cancer of the esophagus. Value of immunodetection of protein p53. Gastroenterol Clin Biol 19:465-474
17. Skandalakis JE, Ellis H (2000) Embryologic and anatomic basis of esophageal surgery. Surg Clin North Am 80:85-115
18. Al-Sarraf M, Martz K, Herskovic, et al (1997) A progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284
19. Cooper JS, Guo MD, Herskovic A, et al (1999) Chemoradiotherapy for locally advanced esophageal cancer. JAMA 281:1623-1627
20. Roth JA, Putnam JB Jr (1994) Surgery for cancer of the esophagus. Semin Oncol 21:453-461
21. Krasna MJ (1999) Surgical staging and surgical treatment in esophageal cancer. Semin Oncol 26:9-11
22. Brown JM (2000) Tumor radiosensitivity: it's the subpopulations that count. Int J Radiat Biol Relat Stud Phys Chem Med 47:549-550
23. Koukourakis M, Giatromanolaki A, Sivridis E, Fezouldis I (2000) Cancer vascularization: implications in radiotherapy. Int J Radiat Biol Relat Stud Phys Chem Med 48:545-553
24. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 57:13-19
25. Overgaard J, Hansen HS, Andersen AP, et al (1989) Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Biol Relat Stud Phys Chem Med 16:1065-1068
26. Brizel DM, Dodge RK, Clough RW, Dewhirst MW (1999) Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53:113-117